Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A51K-035/78
A61K-031/35
출원번호
US-0053625
(2001-11-02)
§371/§102 date
19990208
(19990208)
발명자
/ 주소
Castillo, Gerardo
Choi, Paula Y.
Nguyen, Elizabeth
Snow, Alan D.
출원인 / 주소
ProteoTech, Inc.
인용정보
피인용 횟수 :
2인용 특허 :
5
초록▼
Assay-guided affinity fractionation and reverse phase high pressure liquid chromatography (HPLC) methodology to isolate, test and characterize the most active water-soluble ingredients within Cat's Claw, or Uncaria tomentos. These components appear to account for the majority of the amyloid or Aβ fi
Assay-guided affinity fractionation and reverse phase high pressure liquid chromatography (HPLC) methodology to isolate, test and characterize the most active water-soluble ingredients within Cat's Claw, or Uncaria tomentos. These components appear to account for the majority of the amyloid or Aβ fibrillogenesis inhibitory activity. Individual fractions and/or compounds as isolated by HPLC are tested in relevant in vitro and/or animal models, and found to consistently demonstrate inhibition of amyloid or Aβ fibrillogenesis. Related extraction methods are disclosed.
대표청구항▼
1. A method for isolating amyloid inhibitory components from Uncaria tomentosa, the method comprising the steps:a) adding 4000 ml of methanol to 1 kg of Uncaria tomentosa and mixing; b) centrifuging the mixture at ×2,500 g using a centrifuge for 30 minutes and pouring off the supernatant from a rema
1. A method for isolating amyloid inhibitory components from Uncaria tomentosa, the method comprising the steps:a) adding 4000 ml of methanol to 1 kg of Uncaria tomentosa and mixing; b) centrifuging the mixture at ×2,500 g using a centrifuge for 30 minutes and pouring off the supernatant from a remaining residue; c) adding a second volume of methanol to the residue and repeating step b; d) combining the supernatants from step b and c and evaporating until reduced in volume to about 4-5% of the volume of the supernatents using a rotary evaporator at 50° C.; e) taking the reduced volume, washing 4 times with 300 ml of petroleum ether, and discarding the ether layer; f) evaporating the methanol to dryness to form a solid material using a rotary evaporator at 50° C.; g) extracting the solid material 5 times with 150 ml of distilled water, followed by centrifugation at 2,500×g for 30 minutes each time; h) combining the supernatants from step g and then lypohilizing using a freeze-dryer; i) dissolving the resulting lypohilized extract into about 500 ml of distilled water, and applying 50-100 ml portions of the dissolved extract to a 400 ml LH-20 column equilibrated j) eluting the LH-20 column with ?3 column volumes of distilled water and discarding the amber/yellow eluate; k) eluting the LH-20 column with ?3 column volumes of methanol, collecting the eluate and evaporating it to dryness using a rotary evaporator at 50° C; l) dissolving the product of step k in water to a concentration of ?80 mg/ml and applying 5 ml at a time to a 10 gm disposable C18 SPE column equilibrated in solvent A, where solvent A is 95% water/5% acetonitrile/0.1% TFA; m) washing the column with 3 volumes of solvent A and discarding the eluate; n) eluting the column with 3 volumes of solvent A containing 12.5% solvent B, where solvent B is 95% acentronitrile/5% water/0.1% TFA, and lyophilizing the eluate; o) injecting 50 mg portions of the lyophilized eluate of step n into a Hewlett-Packard 1100 Series HPLC instrument with diode array detector, fitted with a 2.2 cm×25 cm Vydac 218TP1022 C18 reverse-phase column maintained at 25° C. and at a flow rate of 5 ml/min; p) eluting the sample with the following solvent profile, 10% solvent B for minutes 0 to 20, 10-100% solvent B gradient for minutes 20 to 30, and 100-10% solvent B gradient for minutes 30-31; and q) seperating and collecting at least one fraction selected from the following fractions: fraction G (?13-14 minutes), fraction F (?15-16 minutes), fraction H (?17-20 minutes), fraction I (?21 minutes), fraction J (?22-23 minutes), fraction K1 (?24 minutes), fraction K2 (?25 minutes), fraction L (?26-27 minutes), fraction M (?27 -28 minutes), and fraction N (?28-29 minutes). 2. A method for isolating amyloid inhibitory components from Uncaria tomentosa, the method comprising the steps:a) dissolving a quantity of Uncaria tomentosa in one or more volumes of methanol; b) seperating and combining the supernatant from each volume, and reducing it in volume through evaporation; c) taking the reduced volume, washing it with petroleum ether and discarding any ether layer, and evaporating any remaining methanol to dryness to form a solid material; d) extracting the solid material with a plurality of volumes of distilled water and combining the supernatant volumes, and then lyophilizing using a freeze-dryer; e) dissolving the resulting lyophilized extract into about 500 ml of distilled water, and applying 50-100 ml portions of the dissolved extract to a 400 ml LH-20 column equilibrated with distilled water; f) eluting the LH-20 column with ?3 column volumes of distilled water and discarding the amber/yellow eluate; g) eluting the LH-20 column with ?3 column volumes of methanol, collecting the eluate and evaporating it to dryness; h) dissolving the product of step g in water to a concentration of ?80 mg/ml and applying 5 ml at a time to 10 gm disposable C18 SPE column equilibrated in solvent A, where solvent A is 95% water/5% acetonitrile/0.1% TFA; i) washing the C18 SPE column with 3 volumes of solvent A and discarding the eluate; j) eluting the column with 3 volumes of solvent A containing 12.5% solvent B, where solvent B is 95% acentonitrile/5% water/0.1% TFA, and lyophilizing the eluate; k) injecting 50 mg portions of the lyophilized eluate of step j into a Hewlett-Packard 1100 Series HPLC instrument, fitted with a Vydac 218TP1022 C18 reverse-phase column or the like, and maintained at about 25° C. and at a flow rate of 5 ml/min; l) eluting the sample with the following solvent profile, 10% solvent B for minutes 0 to 20, 10-100% solvent B gradient for minutes 20 to 30, and 100-10% solvent B gradient for minutes 30-31; and m) seperating and collecting at least one fraction selected from the following fractions: fraction G (?13-14 minutes), fraction F (?15-16 minutes), fraction H (?17-20 minutes), fraction I (?21 minutes), fraction J (?22-23 minutes), fraction K1 (?24 minutes), fraction K2 (?25 minutes), fraction L (?26-27 minutes), fraction M (?27-28 minutes), and fraction N (?28?29 minutes).
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (5)
Gerardo Castillo ; Alan D. Snow, Composition and methods for inhibiting the formation of brain amyloid deposits.
Castillo, Gerardo; Snow, Alan D., Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer's Disease and other amyloidoses.
Masquelier Jack (Parc des Tourelles FRX), Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.